Sonazoid-enhanced ultrasonography for evaluation of the enhancement patterns of focal liver tumors in the late phase by intermittent imaging with a high mechanical index

Journal of Ultrasound in Medicine

Volumn 28, Issue 4, 2009, Pages 439-448

  Luo, Wen ^a,b   Numata, Kazushi ^a   Kondo, Masaaki ^a   Morimoto, Manabu ^a   Sugimori, Kazuya ^a   Hirasawa, Kingo ^a   Nozaki, Akito ^a   Zhou, Xiaodong ^b   Tanaka, Katsuaki ^a  

^a YOKOHAMA CITY UNIVERSITY MEDICAL CENTER   (Japan)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Contrast enhanced ultrasonography; Liver neoplasms; Sonazoid

Indexed keywords

PATHOLOGY; TUMORS;

CONTRAST-ENHANCED ULTRASONOGRAPHY; FRAMES PER SECONDS; INTRAVENOUS INJECTIONS; LIVER NEOPLASMS; MECHANICAL INDICES; NODULAR ENHANCEMENT; POSITIVE PREDICTIVE VALUES; SONAZOID;

ULTRASONOGRAPHY;

PERFLUBUTANE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTRAST ENHANCEMENT; CONTROLLED STUDY; FEMALE; GRAY SCALE ECHOGRAPHY; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER HEMANGIOMA; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; NODULAR HYPERPLASIA; SENSITIVITY AND SPECIFICITY; SINGLE BLIND PROCEDURE;

EID: 65949116368     PISSN: 02784297     EISSN: None     Source Type: Journal    
DOI: 10.7863/jum.2009.28.4.439     Document Type: Article

References (29)

1. Postema M, Schmitz G. Bubble dynamics involved in ultrasonic imaging. Expert Rev Mol Diagn 2006; 6:493-502. (Pubitemid 44174350)
2. Wink MH, Wijkstra H, De La Rosette JJ, Grimbergen CA. Ultrasound imaging and contrast agents: a safe alternative to MRI? Minim Invasive Ther Allied Technol 2006; 15:93-100.
3. Quaia E. Microbubble ultrasound contrast agents: an update. Eur Radiol 2007; 17:1995-2008. (Pubitemid 47097457)
4. Puttemans T. Update on abdominal imaging: contrast enhanced ultrasonography. JBR-BTR 2007; 90:497-502.
5. Correas JM, Bridal L, Lesavre A, Méjean A, Claudon M, Hélénon O. Ultrasound contrast agents: properties, principles of action, tolerance, and artifacts. Eur Radiol 2001; 11:1316-1328. (Pubitemid 32755614)
6. Kim TK, Choi BI, Han JK, Hong HS, Park SH, Moon SG. Hepatic tumors: contrast agent-enhancement patterns with pulse-inversion harmonic US. Radiology 2000; 216:411-417. (Pubitemid 30599858)
7. Yücel C, Ozdemir H, Gürel S, Ozer S, Araç M. Detection and differential diagnosis of hepatic masses using pulse inversion harmonic imaging during the liver-specific late phase of contrast enhancement with Levovist. J Clin Ultrasound 2002; 30:203-212. (Pubitemid 34465101)
8. Cosgrove D. Ultrasound contrast agents: an overview. Eur J Radiol 2006; 60:324-330.
9. Burns PN, Wilson SR, Simpson DH. Pulse inversion imaging of liver blood flow: improved method for characterizing focal masses with microbubble contrast. Invest Radiol 2000; 35:58-71. (Pubitemid 30033608)
10. Migaleddu V, Virgilio G, Turilli D, et al. Characterization of focal liver lesions in real time using harmonic imaging with high mechanical index and contrast agent Levovist. AJR Am J Roentgenol 2004; 182:1505-1512.
11. Isozaki T, Numata K, Kiba T, et al. Differential diagnosis of hepatic tumors by using contrast enhancement patterns at US. Radiology 2003; 229:798-805.
12. Numata K, Isozaki T, Morimoto M, et al. Prospective study of differential diagnosis of hepatic tumors by pattern-based classification of contrast-enhanced sonography. World J Gastroenterol 2006; 12:6290-6298.
13. Soye JA, Mullan CP, Porter S, Beattie H, Barltrop AH, Nelson WM. The use of contrast-enhanced ultrasound in the characterisation of focal liver lesions. Ulster Med J 2007; 76:22-25. (Pubitemid 46157345)
14. Pompili M, Riccardi L, Semeraro S, et al. Contrast-enhanced ultrasound assessment of arterial vascularization of small nodules arising in the cirrhotic liver. Dig Liver Dis 2008; 40:206-215.
15. von Herbay A, Vogt C, Häussinger D. Late-phase pulse-inversion sonography using the contrast agent Levovist: differentiation between benign and malignant focal lesions of the liver. AJR Am J Roentgenol 2002; 179:1273-1279. (Pubitemid 35204386)
16. von Herbay A, Vogt C, Willers R, Häussinger D. Real-time imaging with the sonographic contrast agent SonoVue: differentiation between benign and malignant hepatic lesions. J Ultrasound Med 2004; 23:1557-1568. (Pubitemid 39586861)
17. Quaia E, Calliada F, Bertolotto M, et al. Characterization of focal liver lesions with contrast-specific US modes and a sulfur hexafluoride-filled microbubble contrast agent: diagnostic performance and confidence. Radiology 2004; 232:420-430.
18. Bryant TH, Blomley MJ, Albrecht T, et al. Improved characterization of liver lesions with liver-phase uptake of liver-specific microbubbles: prospective multicenter study. Radiology 2004; 232:799-809.
19. Hatanaka K, Kudo M, Minami Y, et al. Differential diagnosis of hepatic tumors: value of contrast-enhanced harmonic sonography using the newly developed contrast agent, Sonazoid. Intervirology 2008; 51(suppl 1):61-69.
20. Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology 2005; 42:1208-1236. (Pubitemid 43112690)
21. Lee WJ, Lim HK, Jang KM, et al. Radiologic spectrum of cholangiocarcinoma: emphasis on unusual manifestations and differential diagnoses. Radiographics 2001; 21:S97-S116.
22. Cosgrove DO. Basic principles of the use of microbubbles. In: Dawson P, Cosgrove DO, Grainger RG (eds). Textbook of Contrast Media. Oxford, England: Isis Medical; 1999:465-485.
23. Wilson SR, Burns PN, Muradali D, Wilson JA, Lai X. Harmonic hepatic US with microbubble contrast agent: initial experience showing improved characterization of hemangioma, hepatocellular carcinoma, and metastasis. Radiology 2000; 215:153-161. (Pubitemid 30190524)
24. Nakano H, Ishida Y, Hatakeyama T, et al. Contrast-enhanced intraoperative ultrasonography equipped with late Kupffer-phase image obtained by Sonazoid in patients with colorectal liver metastases. World J Gastroenterol 2008; 14:3207-3211.
25. Forsberg F, Goldberg BB, Liu JB, Merton DA, Rawool NM, Shi WT. Tissue-specific US contrast agent for evaluation of hepatic and splenic parenchyma. Radiology 1999; 210:125-132. (Pubitemid 29004293)
26. Albrecht T, Blomley MJK, Burns PN, et al. Improved detection of hepatic metastases with pulse-inversion US during the liver-specific phase of SHU 508A: multicenter study. Radiology 2003; 227:361-370. (Pubitemid 36514748)
27. Dietrich CF, Ignee A, Trojan J, Fellbaum C, Schuessler G. Improved characterisation of histologically proven liver tumours by contrast enhanced ultrasonography during the portal venous and specific late phase of SHU 508A. Gut 2004; 53:401-405. (Pubitemid 38241338)
28. Numata K, Morimoto M, Ogura T, et al. Ablation therapy guided by contrast-enhanced sonography with Sonazoid for hepatocellular carcinoma lesions not detected by conventional sonography. J Ultrasound Med 2008; 27:395-406.
29. Luo W, Numata K, Morimoto M, et al. Three-dimensional contrast-enhanced sonography of vascular patterns of focal liver tumors: pilot study of visualization methods. AJR Am J Roentgenol 2009; 192:165-173.